tiprankstipranks
Trending News
More News >
IQVIA Holdings Inc (IQV)
NYSE:IQV
US Market
Advertisement

IQVIA Holdings (IQV) Stock Forecast & Price Target

Compare
995 Followers
See the Price Targets and Ratings of:

IQV Analyst Ratings

Strong Buy
18Ratings
Strong Buy
14 Buy
4 Hold
0 Sell
Based on 18 analysts giving stock ratings to
IQVIA
Holdings
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

IQV Stock 12 Month Forecast

Average Price Target

$217.79
▲(8.43% Upside)
Based on 18 Wall Street analysts offering 12 month price targets for IQVIA Holdings in the last 3 months. The average price target is $217.79 with a high forecast of $240.00 and a low forecast of $200.00. The average price target represents a 8.43% change from the last price of $200.86.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"138":"$138","241":"$241","163.75":"$163.8","189.5":"$189.5","215.25":"$215.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":240,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$240.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":217.79,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$217.79</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":200,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$200.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[138,163.75,189.5,215.25,241],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2025","6":"Apr<br/>2025","9":"Jul<br/>2025","12":"Oct<br/>2025","25":"Oct<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,203.79,206.57538461538462,209.36076923076922,212.14615384615385,214.93153846153845,217.71692307692308,220.50230769230768,223.2876923076923,226.0730769230769,228.85846153846154,231.64384615384614,234.42923076923077,237.2146153846154,{"y":240,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,203.79,204.86692307692306,205.94384615384615,207.02076923076922,208.0976923076923,209.17461538461538,210.25153846153844,211.32846153846154,212.4053846153846,213.48230769230767,214.55923076923077,215.63615384615383,216.71307692307693,{"y":217.79,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,203.79,203.49846153846153,203.20692307692306,202.9153846153846,202.62384615384616,202.3323076923077,202.04076923076923,201.74923076923076,201.4576923076923,201.16615384615383,200.8746153846154,200.58307692307693,200.29153846153847,{"y":200,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":231.37,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":209.16,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":201.79,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 52,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":196.51,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 44,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":201.36,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 43,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":188.8,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":171.24,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":151.1,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":139.1,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":162.61,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":182.45,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":183.74,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":203.79,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$240.00Average Price Target$217.79Lowest Price Target$200.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Evercore ISI
$220$240
Buy
19.49%
Upside
Reiterated
10/08/25
Iqvia price target raised to $240 from $220 at Evercore ISIIqvia price target raised to $240 from $220 at Evercore ISI
Barclays Analyst forecast on IQV
Barclays
Barclays
$185$200
Hold
-0.43%
Downside
Reiterated
10/02/25
Iqvia price target raised to $200 from $185 at BarclaysIqvia price target raised to $200 from $185 at Barclays
TR | OpenAI - 4o Analyst forecast on IQV
TR | OpenAI - 4o
TR | OpenAI - 4o
$206$217
Buy
8.04%
Upside
Reiterated
10/01/25
AI Generated ArticleAI Generated Article
CFRA Analyst forecast on IQV
Unknown Analyst
CFRA
Not Ranked
CFRA
$216
Buy
7.54%
Upside
Upgraded
09/18/25
Positive Report for IQVIA Holdings (IQV) from CFRA
Robert W. Baird Analyst forecast on IQV
Robert W. Baird
Robert W. Baird
$196$206
Hold
2.56%
Upside
Reiterated
09/15/25
Robert W. Baird Reaffirms Their Hold Rating on IQVIA Holdings (IQV)Baird analyst Eric Coldwell raised the price target on IQVIA Holdings (NYSE: IQV) to $206.00 (from $196.00) while maintaining a Neutral rating.
Jefferies Analyst forecast on IQV
Jefferies
Jefferies
$195$225
Buy
12.02%
Upside
Upgraded
09/08/25
Iqvia upgraded to Buy from Hold at JefferiesIqvia upgraded to Buy from Hold at Jefferies
Truist Financial Analyst forecast on IQV
Truist Financial
Truist Financial
Buy
Reiterated
09/03/25
Truist Financial Sticks to Their Buy Rating for IQVIA Holdings (IQV)
Leerink Partners Analyst forecast on IQV
Leerink Partners
Leerink Partners
Buy
Reiterated
09/02/25
Stability and Growth Prospects Drive Buy Rating for IQVIA Holdings Amid Leadership Transition
TD Cowen
$206
Buy
2.56%
Upside
Reiterated
09/02/25
TD Cowen Keeps Their Buy Rating on IQVIA Holdings (IQV)
William Blair Analyst forecast on IQV
William Blair
William Blair
Buy
Reiterated
09/02/25
IQVIA Holdings: Strong Buy Rating Amid CFO Transition and Growth ProspectsWe view the following as key risks for IQVIA: 1) a slowdown in the R&D spending environment due to lower end-market pricing or other exogenousfactors; 2) a material reduction in the amount of biotech funding; and 3) increased competitive pricing pressure in the clinical CRO industry. Blair | Building | 150 North Riverside Plaza | Chicago, IL 60606 | +1 312 236 1600 | www.williamblair.com This is not in any sense a solicitation or offer of the purchase or sale of securities. The factual statements herein have been taken from sources we believe to be reliable, but such statements are made without any representation as to accuracy or completeness or otherwise. Opinions expressed are our own unless otherwise stated. Prices shown are approximate.
Deutsche Bank  Analyst forecast on IQV
Deutsche Bank
Deutsche Bank
$200$220
Buy
9.53%
Upside
Reiterated
07/29/25
Deutsche Bank Remains a Buy on IQVIA Holdings (IQV)Deutsche Bank analyst Justin Bowers raised the price target on IQVIA Holdings (NYSE: IQV) to $220.00 (from $200.00) while maintaining a Buy rating.
Stifel Nicolaus Analyst forecast on IQV
Stifel Nicolaus
Stifel Nicolaus
$211$234
Buy
16.50%
Upside
Reiterated
07/28/25
Stifel Nicolaus Remains a Buy on IQVIA Holdings (IQV)
Mizuho Securities Analyst forecast on IQV
Mizuho Securities
Mizuho Securities
$190$225
Buy
12.02%
Upside
Reiterated
07/25/25
Mizuho Securities Reaffirms Their Buy Rating on IQVIA Holdings (IQV)Mizuho analyst Ann Hynes raised the price target on IQVIA Holdings (NYSE: IQV) to $225.00 (from $190.00) while maintaining a Outperform rating.
UBS
$185$225
Buy
12.02%
Upside
Reiterated
07/23/25
Iqvia price target raised to $225 from $185 at UBSIqvia price target raised to $225 from $185 at UBS
Citi
$160$200
Hold
-0.43%
Downside
Reiterated
07/23/25
Citi Sticks to Their Hold Rating for IQVIA Holdings (IQV)
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Evercore ISI
$220$240
Buy
19.49%
Upside
Reiterated
10/08/25
Iqvia price target raised to $240 from $220 at Evercore ISIIqvia price target raised to $240 from $220 at Evercore ISI
Barclays Analyst forecast on IQV
Barclays
Barclays
$185$200
Hold
-0.43%
Downside
Reiterated
10/02/25
Iqvia price target raised to $200 from $185 at BarclaysIqvia price target raised to $200 from $185 at Barclays
TR | OpenAI - 4o Analyst forecast on IQV
TR | OpenAI - 4o
TR | OpenAI - 4o
$206$217
Buy
8.04%
Upside
Reiterated
10/01/25
AI Generated ArticleAI Generated Article
CFRA Analyst forecast on IQV
Unknown Analyst
CFRA
Not Ranked
CFRA
$216
Buy
7.54%
Upside
Upgraded
09/18/25
Positive Report for IQVIA Holdings (IQV) from CFRA
Robert W. Baird Analyst forecast on IQV
Robert W. Baird
Robert W. Baird
$196$206
Hold
2.56%
Upside
Reiterated
09/15/25
Robert W. Baird Reaffirms Their Hold Rating on IQVIA Holdings (IQV)Baird analyst Eric Coldwell raised the price target on IQVIA Holdings (NYSE: IQV) to $206.00 (from $196.00) while maintaining a Neutral rating.
Jefferies Analyst forecast on IQV
Jefferies
Jefferies
$195$225
Buy
12.02%
Upside
Upgraded
09/08/25
Iqvia upgraded to Buy from Hold at JefferiesIqvia upgraded to Buy from Hold at Jefferies
Truist Financial Analyst forecast on IQV
Truist Financial
Truist Financial
Buy
Reiterated
09/03/25
Truist Financial Sticks to Their Buy Rating for IQVIA Holdings (IQV)
Leerink Partners Analyst forecast on IQV
Leerink Partners
Leerink Partners
Buy
Reiterated
09/02/25
Stability and Growth Prospects Drive Buy Rating for IQVIA Holdings Amid Leadership Transition
TD Cowen
$206
Buy
2.56%
Upside
Reiterated
09/02/25
TD Cowen Keeps Their Buy Rating on IQVIA Holdings (IQV)
William Blair Analyst forecast on IQV
William Blair
William Blair
Buy
Reiterated
09/02/25
IQVIA Holdings: Strong Buy Rating Amid CFO Transition and Growth ProspectsWe view the following as key risks for IQVIA: 1) a slowdown in the R&D spending environment due to lower end-market pricing or other exogenousfactors; 2) a material reduction in the amount of biotech funding; and 3) increased competitive pricing pressure in the clinical CRO industry. Blair | Building | 150 North Riverside Plaza | Chicago, IL 60606 | +1 312 236 1600 | www.williamblair.com This is not in any sense a solicitation or offer of the purchase or sale of securities. The factual statements herein have been taken from sources we believe to be reliable, but such statements are made without any representation as to accuracy or completeness or otherwise. Opinions expressed are our own unless otherwise stated. Prices shown are approximate.
Deutsche Bank  Analyst forecast on IQV
Deutsche Bank
Deutsche Bank
$200$220
Buy
9.53%
Upside
Reiterated
07/29/25
Deutsche Bank Remains a Buy on IQVIA Holdings (IQV)Deutsche Bank analyst Justin Bowers raised the price target on IQVIA Holdings (NYSE: IQV) to $220.00 (from $200.00) while maintaining a Buy rating.
Stifel Nicolaus Analyst forecast on IQV
Stifel Nicolaus
Stifel Nicolaus
$211$234
Buy
16.50%
Upside
Reiterated
07/28/25
Stifel Nicolaus Remains a Buy on IQVIA Holdings (IQV)
Mizuho Securities Analyst forecast on IQV
Mizuho Securities
Mizuho Securities
$190$225
Buy
12.02%
Upside
Reiterated
07/25/25
Mizuho Securities Reaffirms Their Buy Rating on IQVIA Holdings (IQV)Mizuho analyst Ann Hynes raised the price target on IQVIA Holdings (NYSE: IQV) to $225.00 (from $190.00) while maintaining a Outperform rating.
UBS
$185$225
Buy
12.02%
Upside
Reiterated
07/23/25
Iqvia price target raised to $225 from $185 at UBSIqvia price target raised to $225 from $185 at UBS
Citi
$160$200
Hold
-0.43%
Downside
Reiterated
07/23/25
Citi Sticks to Their Hold Rating for IQVIA Holdings (IQV)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering IQVIA Holdings

1 Month
xxx
Success Rate
11/16 ratings generated profit
69%
Average Return
+1.33%
reiterated a xxx
rating 19 hours ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 68.75% of your transactions generating a profit, with an average return of +1.33% per trade.
3 Months
xxx
Success Rate
21/31 ratings generated profit
68%
Average Return
+2.74%
upgraded a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 67.74% of your transactions generating a profit, with an average return of +2.74% per trade.
1 Year
Success Rate
11/16 ratings generated profit
69%
Average Return
+8.69%
reiterated a buy rating last month
Copying Charles Rhyee's trades and holding each position for 1 Year would result in 68.75% of your transactions generating a profit, with an average return of +8.69% per trade.
2 Years
xxx
Success Rate
12/12 ratings generated profit
100%
Average Return
+42.01%
upgraded a xxx
rating 10 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +42.01% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

IQV Analyst Recommendation Trends

Rating
Jun 25
Jul 25
Aug 25
Sep 25
Oct 25
Strong Buy
2
0
0
0
0
Buy
23
37
26
30
11
Hold
9
11
9
7
3
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
34
48
35
37
14
In the current month, IQV has received 11 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. IQV average Analyst price target in the past 3 months is 217.79.
Each month's total comprises the sum of three months' worth of ratings.

IQV Financial Forecast

IQV Earnings Forecast

Next quarter’s earnings estimate for IQV is $2.97 with a range of $2.92 to $3.05. The previous quarter’s EPS was $2.81. IQV beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year IQV has Preformed in-line its overall industry.
Next quarter’s earnings estimate for IQV is $2.97 with a range of $2.92 to $3.05. The previous quarter’s EPS was $2.81. IQV beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year IQV has Preformed in-line its overall industry.

IQV Sales Forecast

Next quarter’s sales forecast for IQV is $4.07B with a range of $4.03B to $4.11B. The previous quarter’s sales results were $4.01B. IQV beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year IQV has Preformed in-line its overall industry.
Next quarter’s sales forecast for IQV is $4.07B with a range of $4.03B to $4.11B. The previous quarter’s sales results were $4.01B. IQV beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year IQV has Preformed in-line its overall industry.

IQV Stock Forecast FAQ

What is IQV’s average 12-month price target, according to analysts?
Based on analyst ratings, IQVIA Holdings Inc’s 12-month average price target is 217.79.
    What is IQV’s upside potential, based on the analysts’ average price target?
    IQVIA Holdings Inc has 8.43% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is IQV a Buy, Sell or Hold?
          IQVIA Holdings Inc has a consensus rating of Strong Buy which is based on 14 buy ratings, 4 hold ratings and 0 sell ratings.
            What is IQVIA Holdings Inc’s price target?
            The average price target for IQVIA Holdings Inc is 217.79. This is based on 18 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $240.00 ,the lowest forecast is $200.00. The average price target represents 8.43% Increase from the current price of $200.86.
              What do analysts say about IQVIA Holdings Inc?
              IQVIA Holdings Inc’s analyst rating consensus is a Strong Buy. This is based on the ratings of 18 Wall Streets Analysts.
                How can I buy shares of IQV?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis